Global Antibiotic Research & Development Partnership
The Global Antibiotic Research & Development Partnership (GARDP) is a Swiss non-governmental organization based in Geneva, Switzerland. GARDP “engages in public and private sector partnerships to research and develop new drugs that fit public health needs.”1)
History
GARDP was founded in 2016 by the World Health Organization (WHO) and the Drugs for Neglected Diseases Initiative (DNDi).2)
Organization
Affiliations
Name | Position | Notes |
---|---|---|
Marco Cavaleri | Expert3) | Head of Biological Health Threats and Vaccines Strategy at the European Medicines Agency (EMA) |
Partners
GARDP's programming and funding partners include:4)
- Global AMR Innovation Fund (GAMRIF)
- Medecins Sans Frontières (MSF)
- Wits Health Consortium (WHC)
REVIVE
GARDP launched REVIVE in January 2018 to promote the continued acceleration of antimicrobial resistance research and development.5) REVIVE co-organizes the Antimicrobial Chemotherapy Conference with the British Society for Antimicrobial Chemotherapy (BSAC). Additional partners include:
- Gambia Society of Microbiology (GaSoM)
- Open Source Antibiotics (OSA)